Nang Kuang Pharmaceutical Co., Ltd. (1752.TW)
TWD 41.8
(2.45%)
TWD 41.8
(2.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.15 Billion | 1.94 Billion | 1.78 Billion | 1.75 Billion | 1.76 Billion | 1.53 Billion |
| Cost of Revenue | 1.39 Billion | 1.24 Billion | 1.18 Billion | 1.15 Billion | 1.13 Billion | 1.03 Billion |
| Gross Profit | 755.56 Million | 694.9 Million | 594.46 Million | 596.75 Million | 622.3 Million | 499.51 Million |
| Operating Expenses | 495.65 Million | 371.09 Million | 338.01 Million | 371.53 Million | 374.33 Million | 371.87 Million |
| Selling, General and Administrative Expenses | 331.61 Million | 227.28 Million | 204.05 Million | 211.73 Million | 243.56 Million | 217.19 Million |
| Research and Development Expenses | 164.1 Million | 143.8 Million | 133.96 Million | 159.8 Million | 130.77 Million | 154.68 Million |
| Other Expenses | -68 Thousand | 91.17 Million | -26.15 Million | 1.04 Million | 8.13 Million | -4.57 Million |
| Cost and Expenses | 1.89 Billion | 1.61 Billion | 1.52 Billion | 1.52 Billion | 1.51 Billion | 1.41 Billion |
| Operating Income | 259.91 Million | 417.67 Million | 233.75 Million | 230.47 Million | 256.1 Million | 123.06 Million |
| Interest Expense | 7.18 Million | 4.83 Million | 3.53 Million | 4.31 Million | 3.47 Million | 4.49 Million |
| Income Tax Expense | 15.26 Million | 58.62 Million | 38.64 Million | 40.21 Million | 33.38 Million | 16.5 Million |
| Earnings before Tax | 213.67 Million | 410.62 Million | 234.76 Million | 223.6 Million | 250.82 Million | 117.73 Million |
| Net Income | 198.4 Million | 351.99 Million | 196.11 Million | 183.39 Million | 217.44 Million | 101.23 Million |
| Earnings Per Share Basic | 1.96 | 3.49 | 1.94 | 1.82 | 2.17 | 1.00 |
| Earnings Per Share Diluted | 1.96 | 3.48 | 1.94 | 1.81 | 2.17 | 1.00 |
| Weighted Average Shares Outstanding | 100.98 Million | 100.98 Million | 100.98 Million | 100.98 Million | 100.16 Million | 100.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 101.15 Million | 101.22 Million | 101.23 Million | 101.19 Million | 100.38 Million | 101.09 Million |
| Gross Margin | 0.35 | 0.36 | 0.33 | 0.34 | 0.35 | 0.32 |
| EBIT Margin | 0.19 | 0.31 | 0.23 | 0.24 | 0.25 | 0.21 |
| Profit Margin | 0.09 | 0.18 | 0.11 | 0.10 | 0.12 | 0.07 |
| EBITDA | 402.69 Million | 591.56 Million | 417.82 Million | 412.99 Million | 447 Million | 318.31 Million |
| Earnings Before Tax Margin | 0.12 | 0.22 | 0.13 | 0.13 | 0.15 | 0.08 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 512.29 Million | 528.46 Million | 516.3 Million | 2.15 Billion | 537.05 Million | 523.77 Million |
| Cost of Revenue | 359.74 Million | 356.99 Million | 333.84 Million | 1.39 Billion | 356.81 Million | 334.44 Million |
| Gross Profit | 152.54 Million | 171.47 Million | 182.46 Million | 755.56 Million | 180.24 Million | 189.33 Million |
| Operating Expenses | 96.08 Million | 107.96 Million | 184.27 Million | 495.65 Million | 106.51 Million | 103.09 Million |
| Selling, General and Administrative Expenses | 57.43 Million | 66.19 Million | 58.78 Million | - | 62.23 Million | 66.09 Million |
| Research and Development Expenses | 38.64 Million | 41.76 Million | 44.43 Million | - | 44.28 Million | 37 Million |
| Other Expenses | 7.87 Million | 5.68 Million | -184.27 Million | -495.65 Million | -8.56 Million | 18.59 Million |
| Cost and Expenses | 455.82 Million | 464.95 Million | 518.12 Million | 1.89 Billion | 463.33 Million | 437.54 Million |
| Operating Income | 56.46 Million | 69.94 Million | -1.81 Million | 259.91 Million | 66.77 Million | 108.87 Million |
| Interest Expense | 635 Thousand | 1.24 Million | 2.3 Million | 7.18 Million | 2.05 Million | 1.47 Million |
| Income Tax Expense | 20.68 Million | 15.45 Million | -39.44 Million | 15.26 Million | 18.83 Million | 15.19 Million |
| Earnings before Tax | 64.81 Million | 70.14 Million | -74.23 Million | 213.67 Million | 65.45 Million | 107.8 Million |
| Net Income | 44.13 Million | 54.69 Million | -34.79 Million | 198.4 Million | 46.62 Million | 92.61 Million |
| Earnings Per Share Basic | 0.44 | 0.54 | -0.34 | - | 0.46 | 0.92 |
| Earnings Per Share Diluted | 0.44 | 0.54 | -0.34 | - | 0.46 | 0.92 |
| Weighted Average Shares Outstanding | 100.98 Million | 101.27 Million | 100.98 Million | 100.98 Million | 100.98 Million | 100.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 101.03 Million | 101.27 Million | 100.98 Million | 101.15 Million | 101.15 Million | 101.04 Million |
| Gross Margin | 0.30 | 0.32 | 0.35 | 0.35 | 0.34 | 0.36 |
| EBIT Margin | 0.20 | 0.22 | 0.11 | - | 0.21 | 0.30 |
| Profit Margin | 0.09 | 0.10 | -0.07 | 0.09 | 0.09 | 0.18 |
| EBITDA | 101.85 Million | 115.86 Million | 54.32 Million | - | 112.48 Million | 154.56 Million |
| Earnings Before Tax Margin | 0.11 | 0.13 | -0.00 | 0.12 | 0.12 | 0.21 |
VIVC
2120
SSRM
6028
PD
4737